Glutamate system genes associated with ventral prefrontal and thalamic volume in pediatric obsessive-compulsive disorder

Brain Imaging and Behavior

Volumn 3, Issue 1, 2009, Pages 64-76

  Arnold, Paul Daniel ^a,d   MacMaster, Frank P ^b   Hanna, Gregory L ^c   Richter, Margaret A ^d   Sicard, Tricia ^d   Burroughs, Eliza ^d   Mirza, Yousha ^b   Easter, Phillip C ^b   Rose, Michelle ^b   Kennedy, James L ^d   Rosenberg, David R ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Anterior cingulate cortex; Genetic association; Glutamate; Obsessive compulsive disorder; Orbitofrontal cortex; Thalamus

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER 3; GLUTAMATE RECEPTOR; GLUTAMIC ACID; IONOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B;

ADOLESCENT; ADULT; ARTICLE; BRAIN SIZE; CHILD; CHILD PSYCHIATRY; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSESSIVE COMPULSIVE DISORDER; ORBITAL FRONTAL CORTEX; PATHOGENESIS; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; THALAMUS; VENTRAL PREFRONTAL CORTEX;

EID: 73649145448     PISSN: 19317557     EISSN: 19317565     Source Type: Journal    
DOI: 10.1007/s11682-008-9050-3     Document Type: Article

References (70)

1. Alvarez, V. A., Ridenour, D. A., & Sabatini, B. L. (2007). Distinct structural and ionotropic roles of NMDA receptors in controlling spine and synapse stability. Journal of Neuroscience, 27(28), 7365-7376 11.
2. Arnold, P. D. (2007). Glutamate genes in obsessive-compulsive disorder including childhood onset cases and neuroimaging. Ph. D. dissertation, University of Toronto, Toronto.
3. Arnold, P. D., Rosenberg, D. R., Mundo, E., Tharmalingam, S., Kennedy, J. L., & Richter, M. A. (2004). Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study. Psychopharmacology, 174(4), 530-538. doi: 10. 1007/s00213-004-1847-1.
4. Arnold, P., Sicard, T., Burroughs, E., MacMaster, F., Mirza, Y., Taormina, P., et al. (2007). Glutamate system genes in pediatric obsessive-compulsive disorder: an imaging genetics study using magnetic resonance spectroscopy. Paper presented at the World Congress of Psychiatric Genetics XV, New York, NY.
5. Arnold, P. D., Sicard, T., Burroughs, E., Richter, M. A., & Kennedy, J. L. (2006). Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Archives of General Psychiatry, 63(7), 769-776. doi: 10. 1001/archpsyc. 63. 7. 769.
6. Atmaca, M., Yildirim, H., Ozdemir, H., Tezcan, E., & Poyraz, A. K. (2007). Volumetric MRI study of key brain regions implicated in obsessive-compulsive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 31(1), 46-52. doi: 10. 1016/j. pnpbp. 2006. 06. 008.
7. Bartel, D. P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116(2), 281-297. doi: 10. 1016/S0092-8674(04)00045-5.
8. Benazon, N. R., Moore, G. J., & Rosenberg, D. R. (2003). Neurochemical analyses in pediatric obsessive-compulsive disorder in patients treated with cognitive-behavioral therapy. Journal of the American Academy of Child and Adolescent Psychiatry, 42(11), 1279-1285. doi: 10. 1097/01. chi. 0000087562. 01900. de.
9. Bronstein, Y., & Cummings, J. (2001). Neurochemistry of frontal-subcortical circuits. In D. Lichter, & J. Cummings (Eds.), Frontal-subcortical circuits in psychiatric and neurological disorders (pp. 59-91). New York: Guilford.
10. Carlsson, M. (2000). On the role of cortical glutamate in obsessive-compulsive disorder in obsessive-compulsive disorder and attention-deficit hyperactivity disorder, two hypothetically phenomenologically antithetical conditions. Acta Psychiatrica Scandinavica, 102, 410-413. doi: 10. 1034/j. 1600-0447. 2000. 102006401. x.
11. Chakrabarty, K., Bhattacharyya, S., Christopher, R., & Khanna, S. (2005). Glutamatergic dysfunction in OCD. Neuropsychopharmacology, 30(9), 1735-1740. doi: 10. 1038/sj. npp. 1300733.
12. Choi, J. S., Kang, D. H., Kim, J. J., Ha, T. H., Lee, J. M., Youn, T., et al. (2004). Left anterior subregion of orbitofrontal cortex volume reduction and impaired organizational strategies in obsessive-compulsive disorder. Journal of Psychiatric Research, 38(2), 193-199. doi: 10. 1016/j. jpsychires. 2003. 08. 001.
13. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale: Lawrence Earlbaum Associates.
14. Coric, V., Milanovic, S., Wasylink, S., Patel, P., Malison, R., & Krystal, J. H. (2003). Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder. Psychopharmacology, 167(2), 219-220.
15. Coric, V., Taskiran, S., Pittenger, C., Wasylink, S., Mathalon, D. H., Valentine, G., et al. (2005). Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial. Biological Psychiatry, 58(5), 424-428. doi: 10. 1016/j. biopsych. 2005. 04. 043.
16. de Moor, C. H., Meijer, H., & Lissenden, S. (2005). Mechanisms of translational control by the 3′ UTR in development and differentiation. Seminars in Cell & Developmental Biology, 16(1), 49-58. doi: 10. 1016/j. semcdb. 2004. 11. 007.
17. Dickel, D. E., Veenstra-VanderWeele, J., Cox, N. J., Wu, X., Fischer, D. J., van Etten-Lee, M., et al. (2006). Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder. Archives of General Psychiatry, 63(7), 778-785. doi: 10. 1001/archpsyc. 63. 7. 778.
18. do Rosario-Campos, M. C., Leckman, J. F., Curi, M., Quatrano, S., Katsovitch, L., Miguel, E. C., et al. (2005). A family study of early-onset obsessive-compulsive disorder. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 136(1), 92-97. doi: 10. 1002/ajmg. b. 30149.
19. Gilbert, A., Moore, G., Keshavan, M., Paulson, L., Narula, V., MacMaster, F., et al. (2000). Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine. Archives of General Psychiatry, 57, 449-456. doi: 10. 1001/archpsyc. 57. 5. 449.
20. Glahn, D. C., Thompson, P. M., & Blangero, J. (2007). Neuroimaging endophenotypes: Strategies for finding genes influencing brain structure and function. Human Brain Mapping, 28(6), 488-501. doi: 10. 1002/hbm. 20401.
21. Gottesman, I. I., & Gould, T. D. (2003). The endophenotype concept in psychiatry: etymology and strategic intentions. The American Journal of Psychiatry, 160(4), 636-645. doi: 10. 1176/appi. ajp. 160. 4. 636.
22. Grant, P., Lougee, L., Hirschtritt, M., & Swedo, S. (2007). An open trial with riluzole, a glutamate antagonist, in children with treatment-resistent obsessive-compulsive disorder. Journal of Child and Adolescent Psychopharmacology, 17, 761-767. doi: 10. 1089/cap. 2007. 0021.
23. Hamilton, M. (1959). The assessment of anxiety states by rating. The British Journal of Medical Psychology, 32(1), 50-55.
24. Hamilton, M. (1967). Development of a rating scale for primary depressive illness. The British Journal of Social and Clinical Psychology, 6(4), 278-296.
25. Hanna, G., Himle, J., Curtis, G., & Gillespie, B. (2005). A family study of obsessive-compulsive disorder with pediatric probands. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 134(1), 13-19. doi: 10. 1002/ajmg. b. 30138.
26. Hanna, G., Veenstra-VanderWeele, J., Cox, N., Boehnke, M., Himle, J., Curtis, G., et al. (2002). Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. American Journal of Medical Genetics, 114(5), 541-552. doi: 10. 1002/ajmg. 10519.
27. Hariri, A. R., Drabant, E. M., Munoz, K. E., Kolachana, B. S., Mattay, V. S., Egan, M. F., et al. (2005). A susceptibility gene for affective disorders and the response of the human amygdala. Archives of General Psychiatry, 62(2), 146-152. doi: 10. 1001/archpsyc. 62. 2. 146.
28. John, B., Enright, A. J., Aravin, A., Tuschl, T., Sander, C., & Marks, D. S. (2004). Human MicroRNA targets. PLoS Biology, 2(11), e363. doi: 10. 1371/journal. pbio. 0020363.
29. Kang, D. H., Kim, J. J., Choi, J. S., Kim, Y. I., Kim, C. W., Youn, T., et al. (2004). Volumetric investigation of the frontal-subcortical circuitry in patients with obsessive-compulsive disorder. The Journal of Neuropsychiatry and Clinical Neurosciences, 16(3), 342-349. doi: 10. 1176/appi. neuropsych. 16. 3. 342.
30. Kaufman, J., Birmaher, B., Brent, D., Rao, U., Flynn, C., Moreci, P., et al. (1997). Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. Journal of the American Academy of Child and Adolescent Psychiatry, 36(7), 980-988. doi: 10. 1097/00004583-199707000-00021.
31. Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 593-602. doi: 10. 1001/archpsyc. 62. 6. 593.
32. Kim, J. J., Lee, M. C., Kim, J., Kim, I. Y., Kim, S. I., Han, M. H., et al. (2001). Grey matter abnormalities in obsessive-compulsive disorder: statistical parametric mapping of segmented magnetic resonance images. The British Journal of Psychiatry, 179, 330-334. doi: 10. 1192/bjp. 179. 4. 330.
33. Lahiri, D., & Nurnberger, J. (1991). A rapid no-enzymatic method for the preparation of HMW DNA from blood for RFLP analysis. Nucleic Acids Research, 19, 5444. doi: 10. 1093/nar/19. 19. 5444.
34. Leckman, J. F., Riddle, M. A., Hardin, M. T., Ort, S. I., Swartz, K. L., Stevenson, J., et al. (1989). The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. Journal of the American Academy of Child and Adolescent Psychiatry, 28(4), 566-573. doi: 10. 1097/00004583-198907000-00015.
35. Meyer-Lindenberg, A., & Weinberger, D. R. (2006). Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nature Reviews. Neuroscience, 7(10), 818-827. doi: 10. 1038/nrn1993.
36. Mirza, Y., Tang, J., Russell, A., Banerjee, S. P., Bhandari, R., Ivey, J., et al. (2004). Reduced anterior cingulate cortex glutamatergic concentrations in childhood major depression. Journal of the American Academy of Child and Adolescent Psychiatry, 43(3), 341-348. doi: 10. 1097/00004583-200403000-00017.
37. Mirza, Y., O'Neill, J., Smith, E. A., Russell, A., Smith, J. M., Banerjee, S. P., et al. (2006). Increased medial thalamic creatine-phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive-compulsive disorder versus major depression and healthy controls. Journal of Child Neurology, 21(2), 106-111. doi: 10. 1177/08830738060210020201.
38. Munafo, M. R., Brown, S. M., & Hariri, A. R. (2008). Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. Biological Psychiatry, 63(9), 852-857. doi: 10. 1016/j. biopsych. 2007. 08. 016.
39. Nestadt, G., Samuels, J., Riddle, M., Bienvenu, J., Liang, K.-Y., Labuda, M., et al. (2000). A family study of obsessive-compulsive disorder. Archives of General Psychiatry, 57, 358-363. doi: 10. 1001/archpsyc. 57. 4. 358.
40. Nordstrom, E. J., & Burton, F. H. (2002). A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry. Molecular Psychiatry, 7(6), 617-625. doi: 10. 1038/sj. mp. 4001144.
41. Papassotiropoulos, A., Stephan, D. A., Huentelman, M. J., Hoerndli, F. J., Craig, D. W., Pearson, J. V., et al. (2006). Common Kibra alleles are associated with human memory performance. Science, 314(5798), 475-478. doi: 10. 1126/science. 1129837.
42. Pauls, D., Alsobrook, J., Goodman, W., Rasmussen, S., & Leckman, J. (1995). A family study of obsessive-compulsive disorder. The American Journal of Psychiatry, 152, 76-84.
43. Pittenger, C., Krystal, J. H., & Coric, V. (2006). Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder. Neurorx, 3(1), 69-81. doi: 10. 1016/j. nurx. 2005. 12. 006.
44. Pujol, J., Soriano-Mas, C., Alonso, P., Cardoner, N., Menchon, J. M., Deus, J., et al. (2004). Mapping structural brain alterations in obsessive-compulsive disorder. Archives of General Psychiatry, 61(7), 720-730. doi: 10. 1001/archpsyc. 61. 7. 720.
45. Rasmussen, S. A., & Eisen, J. L. (1994). The epidemiology and differential diagnosis of obsessive compulsive disorder. The Journal of Clinical Psychiatry, 55(Suppl), 5-10 discussion 11-14.
46. Riffkin, J., Yucel, M., Maruff, P., Wood, S. J., Soulsby, B., Olver, J., et al. (2005). A manual and automated MRI study of anterior cingulate and orbito-frontal cortices, and caudate nucleus in obsessive-compulsive disorder: comparison with healthy controls and patients with schizophrenia. Psychiatry Research, 138(2), 99-113. doi: 10. 1016/j. pscychresns. 2004. 11. 007.
47. Rosenberg, D. R., Benazon, N. R., Gilbert, A., Sullivan, A., & Moore, G. J. (2000b). Thalamic volume in pediatric obsessive-compulsive disorder patients before and after cognitive behavioral therapy. Biological Psychiatry, 48(4), 294-300. doi: 10. 1016/S0006-3223(00)00902-1.
48. Rosenberg, D. R., Keshavan, M. S., O'Hearn, K. M., Dick, E. L., Bagwell, W. W., Seymour, A. B., et al. (1997). Frontostriatal measurement in treatment-naive children with obsessive-compulsive disorder. Archives of General Psychiatry, 54(9), 824-830.
49. Rosenberg, D. R., & Keshavan, M. (1998). Toward a neurodevelopmental model of obsessive-compulsive disorder. Biological Psychiatry, 43, 623-640. doi: 10. 1016/S0006-3223(97)00443-5.
50. Rosenberg, D. R., & Hanna, G. L. (2000). Genetic and imaging strategies in obsessive-compulsive disorder: potential implications for treatment development. Biological Psychiatry, 48(12), 1210-1222. doi: 10. 1016/S0006-3223(00)01073-8.
51. Rosenberg, D. R., MacMillan, S., & Moore, G. (2001). Brain anatomy and chemistry may predict treatment response in paediatric obsessive-compulsive disorder. The International Journal of Neuropsychopharmacology, 4, 179-190. doi: 10. 1017/S1461145701002401.
52. Rosenberg, D. R., MacMaster, F. P., Keshavan, M. S., Fitzgerald, K. D., Stewart, C. M., & Moore, G. J. (2000a). Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. Journal of the American Academy of Child and Adolescent Psychiatry, 39(9), 1096-1103. doi: 10. 1097/00004583-200009000-00008.
53. Rosenberg, D. R., Mirza, Y., Russell, A., Tang, J., Smith, J. M., Banerjee, S. P., et al. (2004). Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls. Journal of the American Academy of Child and Adolescent Psychiatry, 43(9), 1146-1153. doi: 10. 1097/01. chi. 0000132812. 44664. 2d.
54. Scahill, L., Riddle, M. A., McSwiggin-Hardin, M., Ort, S. I., King, R. A., Goodman, W. K., et al. (1997). Children's Yale-Brown obsessive compulsive scale: reliability and validity. Journal of the American Academy of Child and Adolescent Psychiatry, 36(6), 844-852. doi: 10. 1097/00004583-199706000-00023.
55. Smith, E. A., Russell, A., Lorch, E., Banerjee, S. P., Rose, M., Ivey, J., et al. (2003). Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: a magnetic resonance spectroscopy study. Biological Psychiatry, 54(12), 1399-1405. doi: 10. 1016/S0006-3223(03)00474-8.
56. Stewart, S. E., Fagerness, J. A., Platko, J., Smoller, J. W., Scharf, J. M., Illmann, C., et al. (2007). Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 144(8), 1027-1033. doi: 10. 1002/ajmg. b. 30533.
57. Su, A. I., Cooke, M. P., Ching, K. A., Hakak, Y., Walker, J. R., Wiltshire, T., et al. (2002). Large-scale analysis of the human and mouse transcriptomes. Proceedings of the National Academy of Sciences of the United States of America, 99(7), 4465-4470. doi: 10. 1073/pnas. 012025199.
58. Szeszko, P. R., Christian, C., MacMaster, F., Lencz, T., Mirza, Y., Taormina S. P., et al. (2008a). Gray matter structural alterations in psychotropic drug-naive pediatric obsessive-compulsive disorder: An optimized voxel-based morphometry study. The American Journal of Psychiatry, 165(10): 1299-1307.
59. Szeszko, P. R., Hodgkinson, C. A., Robinson, D. G., Derosse, P., Bilder, R. M., Lencz, T., et al. (2008b). DISC1 is associated with prefrontal cortical gray matter and positive symptoms in schizophrenia. Biological Psychology, 79(1), 103-110. doi: 10. 1016/j. biopsycho. 2007. 10. 011.
60. Szeszko, P. R., Lipsky, R., Mentschel, C., Robinson, D., Gunduz-Bruce, H., Sevy, S., et al. (2005). Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Molecular Psychiatry, 10(7), 631-636. doi: 10. 1038/sj. mp. 4001656.
61. Szeszko, P. R., MacMillan, S., McMeniman, M., Chen, S., Baribault, K., Lim, K. O., et al. (2004). Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive-compulsive disorder. The American Journal of Psychiatry, 161(6), 1049-1056. doi: 10. 1176/appi. ajp. 161. 6. 1049.
62. Szeszko, P. R., Robinson, D., Alvir, J. M., Bilder, R. M., Lencz, T., Ashtari, M., et al. (1999). Orbital frontal and amygdala volume reductions in obsessive-compulsive disorder. Archives of General Psychiatry, 56(10), 913-919. doi: 10. 1001/archpsyc. 56. 10. 913.
63. Tabachnik, B. G., & Fidell, L. S. (2001). Using Multivariate Statistics. Toronto: Allyn & Bacon.
64. Turner, J. A., Smyth, P., Macciardi, F., Fallon, J. H., Kennedy, J. L., & Potkin, S. G. (2006). Imaging phenotypes and genotypes in schizophrenia. Neuroinformatics, 4(1), 21-49. doi: 10. 1385/NI: 4: 1: 21.
65. Valente Jr, A. A., Miguel, E. C., Castro, C. C., Amaro Jr, E., Duran, F. L., Buchpiguel, C. A., et al. (2005). Regional gray matter abnormalities in obsessive-compulsive disorder: a voxel-based morphometry study. Biological Psychiatry, 58(6), 479-487. doi: 10. 1016/j. biopsych. 2005. 04. 021.
66. van Grootheest, D. S., Cath, D. C., Beekman, A. T., & Boomsma, D. I. (2005). Twin studies on obsessive-compulsive disorder: a review. Twin Research and Human Genetics, 8(5), 450-458.
67. Wechsler, D. I. (1991). Examiner's manual: Wechsler intelligence scale for Children (3rd ed.). New York: Psychological Corporation.
68. Welch, J. M., Lu, J., Rodriguiz, R. M., Trotta, N. C., Peca, J., Ding, J. D., et al. (2007). Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature, 448(7156), 894-900. doi: 10. 1038/nature06104.
69. Whiteside, S. P., Port, J. D., Deacon, B. J., & Abramowitz, J. S. (2006). A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety. Psychiatry Research, 146(2), 137-147. doi: 10. 1016/j. pscychresns. 2005. 12. 006.
70. Willour, V. L., Yao Shugart, Y., Samuels, J., Grados, M., Cullen, B., Bienvenu 3rd, O. J., et al. (2004). Replication study supports evidence for linkage to 9p24 in obsessive-compulsive disorder. American Journal of Human Genetics, 75(3), 508-513. doi: 10. 1086/423899.